Brittani Cushman - Feb 10, 2023 Form 4 Insider Report for Turning Point Brands, Inc. (TPB)

Role
Sr VP, General Counsel
Signature
/s/ Brittani Cushman
Stock symbol
TPB
Transactions as of
Feb 10, 2023
Transactions value $
$65,314
Form type
4
Date filed
2/14/2023, 08:20 PM
Previous filing
Mar 16, 2022
Next filing
May 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TPB Common Stock Award $94.6K +4.17K +69.26% $22.71 10.2K Feb 10, 2023 Direct F10
transaction TPB Common Stock Tax liability -$33.5K -1.47K -14.48% $22.71 8.71K Feb 10, 2023 Direct F11
transaction TPB Common Stock Award $4.18K +184 +2.11% $22.71 8.89K Feb 10, 2023 Direct F12
holding TPB Common Stock 407 Feb 10, 2023 By Spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TPB Options (2022) 8K Feb 10, 2023 Common Stock 8K $30.46 Direct F8, F9
holding TPB Options (2021) 7K Feb 10, 2023 Common Stock 7K $51.75 Direct F2, F3
holding TPB Options (2020) 6K Feb 10, 2023 Common Stock 6K $14.85 Direct F2, F4
holding TPB Options (2019) 4.8K Feb 10, 2023 Common Stock 4.8K $47.58 Direct F2, F5
holding TPB Options (2018) 4.5K Feb 10, 2023 Common Stock 4.5K $21.21 Direct F2, F6
holding TPB Options (2017) 3.25K Feb 10, 2023 Common Stock 3.25K $15.41 Direct F2, F7
holding TPB Options (2017) 20K Feb 10, 2023 Common Stock 20K $13.00 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
F2 Granted pursuant to the issuer's 2015 Equity Incentive Plan
F3 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023 and 33% of the underlying shares on January 1, 2024.
F4 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022 and 33% of the underlying shares on January 1, 2023.
F5 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022.
F6 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021.
F7 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2018, 33% of the underlying shares on January 1, 2019 and 33% of the underlying shares on January 1, 2020.
F8 The options vest and become exercisable as to 34% of the underlying shares on January 1, 2023, 33% of the underlying shares on January 1, 2024 and 33% of the underlying shares on January 1, 2025.
F9 Granted pursuant to the issuer's 2021 Equity Incentive Plan.
F10 Represents shares issued upon settlement of performance restricted stock units granted to the reporting person in March 2018. The compensation committee of the Board of Directors determined that the performance criteria were met on February 10, 2022. The total reported in Column 5 includes 2,500 restricted stock units and 7,681 shares of common stock.
F11 The reported transaction involves shares withheld for the payment of taxes related to performance restricted stock units that the performance criteria were met on February 10, 2023. The total reported in Column 5 includes 2,500 restricted stock units and 6,207 shares of common stock.
F12 The reported transaction involves shares received as dividends related to performance restricted stock units that the performance criteria were met on February 10, 2023. The total reported in Column 5 includes 2,500 restricted stock units and 6,391 shares of common stock.